Evidence map›Paper›PMID 15016851›Full record

ArticleJournal of virology2004

p16(Ink4a) interferes with Abelson virus transformation by enhancing apoptosis.

Zohar Sachs, Norman E Sharpless, Ronald A DePinho, Naomi Rosenberg

Open access · bronzeAbstract read
In one paragraph

Article in Journal of virology, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.5field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 2 countries.

Zohar SachsDepartment of Pathology, Sackler School of Graduate Biomedical Sciences, Tufts University School of Medicine, Boston, Massachusetts 02111, USA.
Norman E Sharpless
Ronald A DePinho
Naomi Rosenberg
Dana-Farber Cancer Institute · USInstitute of Immunology · HRNational Student Clearinghouse Research Center · US

Funding

RNA TUMOR VIRUS/HEMATOPOIETIC CELLS INTERACTIONSR01CA033771 · NCI · TUFTS UNIVERSITY BOSTON · PI ROSENBERG, NAOMI · 1985 to 2007
$2.6M
RNA TUMOR VIRUS-HEMATOPOIETIC CELL INTERACTIONR37CA033771 · NCI · TUFTS UNIVERSITY BOSTON · PI ROSENBERG, NAOMI · 1993 to 1997
–
NCI NIH HHS CA 33771NCI NIH HHS R01 CA033771
6 · The paper itself

Abstract

Pre-B-cell transformation by Abelson virus (Ab-MLV) is a multistep process in which primary transformants are stimulated to proliferate but subsequently undergo crisis, a period of erratic growth marked by high levels of apoptosis. Inactivation of the p53 tumor suppressor pathway is an important step in this process and can be accomplished by mutation of p53 or down-modulation of p19(Arf), a p53 regulatory protein. Consistent with these data, pre-B cells from either p53 or Ink4a/Arf null mice bypass crisis. However, the Ink4a/Arf locus encodes both p19(Arf) and a second tumor suppressor, p16(Ink4a), that blocks cell cycle progression by inhibiting Cdk4/6. To determine if p16(Ink4a) plays a role in Ab-MLV transformation, primary transformants derived from Arf(-/-) and p16(Ink4a(-/-)) mice were compared. A fraction of those derived from Arf(-/-) animals underwent crisis, and even though all p16(Ink4a(-/-)) primary transformants experienced crisis, these cells became established more readily than cells derived from +/+ mice. Analyses of Ink4a/Arf(-/-) cells infected with a virus that expresses both v-Abl and p16(Ink4a) revealed that p16(Ink4a) expression does not alter cell cycle profiles but does increase the level of apoptosis in primary transformants. These results indicate that both products of the Ink4a/Arf locus influence Ab-MLV transformation and reveal that in addition to its well-recognized effects on the cell cycle, p16(Ink4a) can suppress transformation by inducing apoptosis.

Indexed as

ApoptosisCell Transformation, ViralAbelson murine leukemia virusAnimalsB-LymphocytesCell Line, TransformedCyclin-Dependent Kinase Inhibitor p16Gene DeletionMiceStem CellsTumor Suppressor Protein p14ARFCdkn2a protein, mouseCyclin-Dependent Kinase Inhibitor p16Tumor Suppressor Protein p14ARF

Identifiers

PMID15016851
PMCPMC371071
OpenAlexW2154311846

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.